Riskpilot← Back to searchSign inGet full accessSLETTEBAKKEN LEGESENTER DA
DAActiveOrg 979206992Vilhelm Bjerknes' Vei 21, 5081 BergenGeneral medical practice activities · NACE 8621Est. 19975 employeeswww.slettebakkenlegesenter.no
Revenue 2024
NOK 4,1M
+7% vs 2023
EBITDA margin
-3.0%
+26% vs 2023
Equity ratio
-43.7%
Financial strength
Net profit 2024
NOK -133K
+26% vs 2023
| Revenue | NOK 4,1M | +7% |
| EBITDA | NOK -124K | +26% |
| Net profit | NOK -133K | +26% |
| Total assets | NOK 260K | -14% |
| Equity | NOK -114K | -101% |
| Employees | 5 | — |
Legal name
SLETTEBAKKEN LEGESENTER DA
Org number
979206992
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
13. august 1997
Share capital
—
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Vilhelm Bjerknes' Vei 21, 5081 Bergen
Website
www.slettebakkenlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 298 | 3 639 | 3 509 | 3 830 | 4 090 |
| Staff expenses | −1 584 | −1 839 | −1 880 | −2 078 | −2 048 |
| EBITDA | −99 | 105 | −230 | −168 | −124 |
| Depreciation & amort. | −36 | −23 | −28 | −11 | −9 |
| EBIT | −134 | 81 | −258 | −179 | −133 |
| Net financials | −0 | 0 | −0 | −0 | 0 |
| Profit before tax | −135 | 81 | −258 | −179 | −133 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −135 | 81 | −258 | −179 | −133 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 387 | 419 | 387 | 304 | 260 |
| Equity | −4 | 179 | −9 | −57 | −114 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 391 | 241 | 396 | 361 | 374 |
| Total debt | 391 | 241 | 396 | 361 | 374 |
EBITDA margin
-3.0%
This company
15.8%
Market median
-119% vs market
20202024
Equity ratio
-43.7%
This company
38.2%
Market median
-214% vs market
20202024
Return on equity
-13310800.0%
This company
18.4%
Market median
-72341404% vs market
20202024
Net profit margin
-3.3%
This company
8.1%
Market median
-141% vs market
20202024
Asset turnover
15.72×
This company
1.12×
Market median
+1304% vs market
20202024
Debt / equity
3.29×
This company
0.62×
Market median
-431% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MG Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2020 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 0% | 0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SLETTEBAKKEN LEGESENTER DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Grimsland Wangsholm | Chief Executive Officer | 0 companies |
| Kjersti Beate Pileberg | Board of Directors | 0 companies |
| Helge Aleksander Strand | Board of Directors | 0 companies |
| Roger Veiby | Board of Directors | 0 companies |
| Mats Elias Meguenni | Board of Directors | 0 companies |
| Natalia Basiuk Thune | Board of Directors | 0 companies |
| Edith Helgeland Qvale | Board of Directors | 0 companies |